Ivosidenib – Another feather in the hat of treatment for acute myeloid leukemia

The treatment of acute myeloid leukemia has undergone a paradigm shift in the past few years. Multiple new targeted and nontargeted agents have been approved in the recent past. Isocitrate dehydrogenase (IDH) mutation is one such target that has been identified, and two new drugs, ivosidenib and ena...

Full description

Saved in:
Bibliographic Details
Main Author: Jayachandran Perumal Kalaiyarasi
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2020-01-01
Series:Indian Journal of Medical and Paediatric Oncology
Subjects:
Online Access:http://www.ijmpo.org/article.asp?issn=0971-5851;year=2020;volume=41;issue=4;spage=552;epage=554;aulast=Perumal
Tags: Add Tag
No Tags, Be the first to tag this record!